510(k) Report

510(k) · Cleared

Cleared

sTMS mini

K161663510(k) SpecialCleared Aug 23, 201668-day reviewClass II21 CFR 882.5808

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Eneura, Inc. · OKP Transcranial Magnetic Stimulator For The Treatment Of Migraine Headache

Cleared on Aug 23, 2016 as substantially equivalent to K140094 (Eneura Therapeutics, LLC, 2014) after a 68-day review. Its family tree reaches back 2 generations to 2013.

Decided
Aug 23, 2016
Review
68 days
Class
Class II
Product code
OKP
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN130022 (2013). No later device cites it as a predicate yet.

  1. Root · 2 generations backDEN130022 Neuralieve Cerena Transcranial Magnetic StimulatorEneura Therapeutics · 2013
  2. 1 generation backK140094 Springtms Total Migraine SystemEneura Therapeutics, LLC · 2014
  3. This deviceK161663 sTMS miniEneura, Inc. · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN130022Neuralieve Cerena Transcranial Magnetic StimulatorEneura Therapeutics2013—
−1K140094Springtms Total Migraine SystemEneura Therapeutics, LLC2014—
0 (this device)K161663sTMS miniEneura, Inc.2016—
FIG. 1 — Lineage of K161663, 2013–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OKP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OKP device

  1. #1 K230358 SAVI Dual (TM) Migraine Therapyscore 6.2 · 4 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K140094Springtms Total Migraine System
Summary page 4
…ct Code: OKP Trade Name: sTMS mini Generic/Common Name per 21 CFR§882.5808: Transcranial magnetic stimulator for headache PREDICATE DEVICE(S) [807.92(a)(3)] SpringTMS® (K140094) CONFIDENTIAL 30 510(k)…
Eneura Therapeutics, LLC2014—

Also cleared against K140094: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 3 companies; a new generation was cleared every 2.3 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K140094.

How does its category compare?

All OKP devices

OKP Transcranial Magnetic Stimulator For The Treatment Of Migraine Headache: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · OKP

1in 2023

2013: 12014: 12016: 12017: 12019: 12023: 1
2007high 1 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OKP

Too few OKP 510(k)s in any year since 2007 to give a median.

Recalls per year · OKP

No recall names OKP since 2007.

Adverse event reports per year · OKP

1in 2024

2019: 22024: 1
2007high 2 (2019) · low 0 (2007)2025

MAUDE reports naming product code OKP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20131—00
20141—00
20150—00
20161—00
20171—00
20180—00
20191—02
20200—00
20210—00
20220—00
20231—00
20240—01
20250—00
20260—0—

What is it indicated for?

The eNeura® sTMS mini is indicated for the acute treatment of pain associated with migraine headache with aura.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K161663: sTMS mini.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K161663

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026